Pennsylvania pauses administration of Johnson & Johnson Covid-19 vaccine
April 13, 2021 at 15:12 PM EDT
The decision comes following recommendations from the CDC and FDA after there were six reported cases of rare blood clots in women aged 18 to 46 who received the Johnson & Johnson vaccine out of the nearly 7 million of these doses administered nationwide.
